Cyclobenzaprine Hcl Capsule, Extended Release
Product Images NDC 80425-0292

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hcl (NDC 80425-0292). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 1 (Cyclobenzaprine HCl Er 15mg 80425 0292 01)

Cyclobenzaprine HCL ER 15 mg extended-release capsule label. The label shows the product name, strength, dosage form, and quantity (#30). It is labeled for oral use and manufactured by Advanced Rx Pharmacy of Tennessee, LLC, Nashville, TN. Includes storage instructions (20°-25°C) and comparison information to Amrix with corresponding NDC numbers. Also features a barcode, lot number, expiration date (7/31/2025), and serial number for Impax/Amneal.*

FDA Label Image

Label 2 (Cyclobenzaprine HCl Er 15mg 80425 0292 02)

Cyclobenzaprine HCL ER 15 mg extended-release capsule packaging label. The label includes the product name, strength, dosage form, and a quantity of 60 capsules. It also features the labeler Advanced Rx Pharmacy of Tennessee, LLC, and storage instructions to keep between 20°-25°C (68°-77°F). A barcode and lot number with expiration date 7/31/2025 are visible.*

FDA Label Image

Label 3 (Cyclobenzaprine HCl Er 15mg 80425 0292 03)

Cyclobenzaprine HCL Extended Release 15 mg capsule packaging label. The label includes the product name, strength, dosage form, and manufacturer Advanced Rx Pharmacy of Tennessee, LLC. It also contains storage information, barcode, lot number, expiration date (07/31/2025), and NDC codes. The package indicates a quantity of 90 capsules.*

FDA Label Image

Description (Description)

Chemical structure diagram of Cyclobenzaprine Hydrochloride (Cyclobenzaprine HCL), showing the molecular framework with associated chemical groups and hydrochloride notation.*

FDA Label Image

Fig 1 (Fig1)

FDA Label Image

Fig 2 (Fig2)

An instructional illustration showing a person holding a capsule with both hands, demonstrating how to prepare or administer the capsule. The capsule appears to be split or opened slightly between the thumbs and fingers.*

FDA Label Image

Fig 3 (Fig3)

Instructional illustration showing how to open a child-resistant safety cap on a medication bottle by pressing down and turning it simultaneously. The image depicts two hands interacting with the cap, with directional arrows indicating the required movements.*

FDA Label Image

Fig 4 (Fig4)

An instructional illustration showing a hand sprinkling capsule contents onto food, likely demonstrating how to administer the medication by opening the capsule and mixing the contents.*

FDA Label Image

Fig 5 (Fig5)

A black and white line drawing illustration showing a woman holding a capsule near her mouth, demonstrating the act of taking an oral capsule dosage. The image relates to medication administration by mouth.*

FDA Label Image

Fig 6 (Fig6)

An illustration showing a person drinking from a glass, demonstrating the oral route of administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.